<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date20194625.8 (espacenet)  (Federated)  (European Patent Register), 20130521
Patent/reg. no. and dateDK/EP 3791896, 20240110
Publication date20210317
Priority no. and dateWO PCT/EP2012/002210, 20120523
EP pub. no. and date EP 3791896 20210317
Effective date
Applicant/ownerAstellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome,
Chuo-ku
Tokyo 103-8411, JP,
TRON - Translationale Onkologie an der
Universitätsmedizin der Johannes Gutenberg-
Universität Mainz gemeinnützige GmbH, Freiligrathstrasse 12
55131 Mainz, DE
Applicant ref. no.V2401-025-DK
InventorTÜRECI, Özlem, Philipp-von-Zabern-Platz 1
55116 Mainz, DE,
SAHIN, Ugur, Philipp-von-Zabern-Platz 1
55116 Mainz, DE,
MITNACHT-KRAUS, Rita, Taunusstrasse 45
61169 Friedberg, DE,
JACOBS, Stefan, Denis, Friedenstrasse 7
55252 Mainz-Kastel, DE,
UTSCH, Magdalena, Jadwiga, Fingerkrautweg 30b
55262 Heidesheim am Rhein, DE,
HEINZ, Cornelia, Adriana, Maria, Auf den Elfmorgen 22
55278Dalheim, DE,
STADLER, Christiane, Regina, Fritz-Bockius Strasse 13
64625 Bensheim, DE
RepresentativeNORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K
Opponent
IPC ClassA61K 39/395 (2006.01) , A61K 45/06 (2006.01) , C07K 16/30 (2006.01) 
TitleKOMBINATIONSTERAPI MED ANTISTOFFER MOD CLAUDIN 18.2 TIL CANCERBEHANDLING
Int. application no.
Int. publication no.
Related patent (certificate)
StatusRettet DK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact